Pierre joined Amadeus Capital Partners in 2012 and leads early stage Health & Bio investments at Amadeus. He is on the boards of Inotec, Ori Biotech, Doctify, Congenica, PhoreMost, Quibim and oversees our investments in Lumeon and Organox.
Pierre brings operational experience to these investments, having managed the growth of several life science businesses in Asia and Europe. During a decade at biotech company Avesthagen, he guided the group’s strategy and European activities, contributing to acquisitions, joint ventures and exits.
Pierre is French and holds an MSc in Environmental Economics (Hons.-SciencesEco) from Université de Provence, France and a BSc in Finance (Math Spe.-SciencesEco) from Université Louis Pasteur, France. He has attended executive programs at Harvard, MIT and Stanford.
Pierre speaks French and English.
Meet Pierre at:
5th October 2020
2nd Annual European HealthTech Innovation Days
Pierre Socha will be attending The 2nd Annual European HealthTech Innovation Days event in Paris. The aim of the two day event is to drive and foster collaborations by bringing together the European healthcare community to discuss new trends in research & development. In addition to the ongoing private networking, attendees can expect roundtables focused on critical economic and political issues that impact health technology developments.
18th November 2020
European Wound Management Association Annual Conference
Pierre Socha will be attending the annual European Wound Management Association Conference (EWMA) in London. The EWMA Conference is organised in cooperation with Tissue Viability Society (TVS) and offers high-level scientific presentations, networking activities and an excellent opportunity to exchange knowledge and experience with international colleagues.
More from Pierre
Blog: 9th January 2020
Blog: 18th December 2019